Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy.

× No keyword cloud information.

13 in total

Review 1. Myeloid disorders after autoimmune disease.

Authors: Prajwal C Boddu; Amer M Zeidan
Journal: Best Pract Res Clin Haematol Date: 2019-02-07 Impact factor: 3.020

Review 2. Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.

Authors: Meenakshi Bewtra; James D Lewis
Journal: Expert Rev Clin Immunol Date: 2010-07 Impact factor: 4.473

3. Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.

Authors: Hélène Théophile; Thierry Schaeverbeke; Ghada Miremont-Salamé; Abdelilah Abouelfath; Valentine Kahn; Françoise Haramburu; Bernard Bégaud
Journal: Drug Saf Date: 2011-07-01 Impact factor: 5.606

4. Mucinous carcinoma in Crohn's disease originating in a fistulous tract.

Authors: Hugh J Freeman; Tom Perry; Douglas L Webber; Silvia D Chang; Mong-Yang Loh
Journal: World J Gastrointest Oncol Date: 2010-07-15

5. Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System.

Authors: Eric D Shah; Elliot S Coburn; Anil Nayyar; Kerry Jo Lee; Jenna L Koliani-Pace; Corey A Siegel
Journal: Aliment Pharmacol Ther Date: 2020-01-28 Impact factor: 8.171

6. Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review.

Authors: Mariko Yabe; L Jeffrey Medeiros; Yahya Daneshbod; Masoud Davanlou; Carlos E Bueso-Ramos; Elisa J Moran; Ken H Young; Roberto N Miranda
Journal: Ann Diagn Pathol Date: 2016-10-18 Impact factor: 2.090

Review 7. TNF-alpha and its inhibitors in cancer.

Authors: Inès Zidi; Souhir Mestiri; Aghleb Bartegi; Nidhal Ben Amor
Journal: Med Oncol Date: 2009-03-11 Impact factor: 3.064

8. Lack of TNFalpha expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK+ TCL) cells from apoptosis.

Authors: Qian Zhang; Hong Y Wang; Gauri Bhutani; Xiaobin Liu; Michele Paessler; John W Tobias; Donald Baldwin; Kunchithapadam Swaminathan; Michael C Milone; Mariusz A Wasik
Journal: Proc Natl Acad Sci U S A Date: 2009-08-26 Impact factor: 11.205

9. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors: Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal: Clin Lymphoma Myeloma Leuk Date: 2012-10-27

10. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.

Authors: María Gómez-García; Maria José Cabello-Tapia; Antonio Damián Sánchez-Capilla; Javier De Teresa-Galván; Eduardo Redondo-Cerezo
Journal: World J Gastroenterol Date: 2013-08-14 Impact factor: 5.742